A Multi-Center Trial of Nepicastat for Cocaine Dependence
Public ClinicalTrials.gov record NCT01704196. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to evaluate the safety and efficacy of Nepicastat in improving the number of subjects that achieve abstinence from cocaine and reducing cocaine use in subjects with cocaine dependence.
Study identification
- NCT ID
- NCT01704196
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 179 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2013 (Type not available)
- Primary completion
- Aug 2014 (Actual)
- Completion
- Dec 2014 (Actual)
- Last update posted
- May 18, 2017
2013 – 2014
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Matrix Institute on Addictions | Los Angeles | California | 90016 | — |
| VA San Diego Healthcare System | San Diego | California | 92161 | — |
| VA Medical Center - Denver, CO | Denver | Colorado | 80220 | — |
| Mountain Manor Treatment Center at Baltimore | Baltimore | Maryland | 21229 | — |
| Pacific Institute for Research and Evaluation | Albuquerque | New Mexico | 87102 | — |
| Columbia University Medical Center | New York | New York | 10019 | — |
| Cincinnati Addiction Research Center | Cincinnati | Ohio | 45220 | — |
| University of Pennsylvania - Treatment Research Center | Philadelphia | Pennsylvania | 19104 | — |
| Michael E. DeBakey VA Medical Center | Houston | Texas | 77030 | — |
| George E. Wahlen VA Medical Center | Salt Lake City | Utah | 84148 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01704196, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2017 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01704196 live on ClinicalTrials.gov.